Xconomy Boston

Tokai Pharmaceuticals Lands $22,000,000 Series D Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=03837a8c-060e-4fd9-9d12-520740733417&Preview=1
Date
5/8/2009
Company Name
Tokai Pharmaceuticals
Mailing Address
One Broadway, 11th floor Cambridge , MA 02142
Company Description
The company develops biopharmaceutical products that focus on endocrine treatment.
Website
http://www.tokaipharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$22,000,000
Transaction Round
Series D
Proceeds Purposes
Proceeds from the financing will be used to advance Tokai’s lead development candidate, TOK-001, into the clinic for the treatment of advanced prostate cancer.
M&A Terms
Venture Investor
Novartis Venture Fund
Venture Investor
Apple Tree Partners